BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program

NEXT STORY
Progenics Highlights Additional Serious Concerns About Velan Capital, L.P.
PREV STORY
Itamar Medical Appoints Jennifer Cook, MD, FAHA, FACC, as Global Medical Director
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Microbiology Data from Paratek Pharmaceuticals Show Omadacycline Effective Against Most Common Skin Infections and Pathogens, Including MRSA

- Microbiology analysis and full results of Phase 3 OASIS study presented at ECCMID ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Reports Second Quarter 2016 Financial Results and Highlights Recent Clinical Progress

NEW YORK, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today reported ...

author_avatar
NASDAQ Market News

Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO

author_avatar
NASDAQ Market News